Coppens, Ryan
Rabinovich, Norka E.
Kanneganti, Raghuveer
Diggs, Herman A.
Wiggs, Kristin
Healey, Travis
Huggenvik, Jodi
Rose, Gregory M.
Gilbert, David G. http://orcid.org/0000-0001-7525-7239
Funding for this research was provided by:
National Institute on Drug Abuse (R01DA31006)
Article History
Received: 5 June 2020
Accepted: 12 January 2021
First Online: 28 January 2021
Compliance with ethical standards
:
: David Gilbert ended grant funding and all other connections with or benefits from R. J. Reynolds Tobacco Company in 1997 and has not received funding from any source other than the National Institutes of Health and the Southern Illinois University Center for Integrated Research in Cognitive & Neural Sciences since that time. He received free nicotine and placebo patches from Glaxo-Smith Kline in 2003. He received a consultation fee from Pfizer in 2003 and co-authored two publications with them in 2004 and 2007. Norka Rabinovich worked with several grant projects from R. J. Reynolds prior to the termination of funding from RJR in 1997. The other authors have no conflicts of interest.